by primrosebiostg | Apr 25, 2025 | Events
Primrose Bio was proud to exhibit and present at the World Vaccine Congress 2025, held April 22–25 in Washington, D.C. Our team shared insights into next-generation solutions for biotherapeutics and vaccine manufacturing, highlighting our Prima RNApols™ platform... 
by primrosebiostg | Mar 26, 2025 | Featured, Press
Significantly increased quality and lower manufacturing costs for long template mRNAs San Diego, Calif. March 26, 2025 – Primrose Bio, Inc. (“Primrose”), a company developing proprietary therapeutic manufacturing technologies, announces the launch of Prima RNApols™... 
by primrosebiostg | Mar 20, 2025 | Events
Primrose Bio was proud to participate in Bio-Europe Spring 2025, held March 17–19 in Italy. Representing the team, Alec Tzianabos connected with global partners to discuss our scalable, efficient, and cost-effective manufacturing solutions for complex biologics.... by primrosebiostg | Jan 17, 2025 | Events
Primrose Bio kicked off the year at JPM Week 2025 in San Francisco, where our executive team — Helge Zieler (CEO), Simon Latimer (CFO), Michele Rubino (CBO), and Louis J. Cantolupo (VP of Business Development) — met with partners, investors, and biotech...